Tri­fec­ta of sick­le cell dis­ease ther­a­pies ex­tend life ex­pectan­cy, but are not cost-ef­fec­tive — ICER

Dif­fer­ent ther­a­peu­tic traits bran­dished by the three ap­proved ther­a­pies for sick­le cell dis­ease all ex­tend life ex­pectan­cy, but their im­pact on qual­i­ty of life is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER